On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.
Arbutus expects to receive around $179 million from Moderna.
Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...